Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications

DJ Drucker - Endocrine reviews, 2020 - academic.oup.com
Abstract Individuals with diabetes are at increased risk for bacterial, mycotic, parasitic, and
viral infections. The severe acute respiratory syndrome (SARS)-CoV-2 (also referred to as …

Diabetes and COVID-19; a bidirectional interplay

P Kazakou, V Lambadiari, I Ikonomidis… - Frontiers in …, 2022 - frontiersin.org
There seems to be a bidirectional interplay between Diabetes mellitus (DM) and coronavirus
disease 2019 (COVID-19). On the one hand, people with diabetes are at higher risk of fatal …

[HTML][HTML] Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration

ML van Zuylen, SE Siegelaar, MP Plummer… - British journal of …, 2024 - Elsevier
Prescriptions and use of glucagon-like peptide-1 (GLP-1) receptor agonists are increasing
dramatically, as indications are expanding from the treatment of diabetes mellitus to weight …

COVID-19: diabetes perspective—pathophysiology and management

S Dallavalasa, SRV Tulimilli, J Prakash… - Pathogens, 2023 - mdpi.com
Recent evidence relating to the impact of COVID-19 on people with diabetes is limited but
continues to emerge. COVID-19 pneumonia is a newly identified illness spreading rapidly …

Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus

AH Hulst, JAW Polderman, SE Siegelaar… - British journal of …, 2021 - bjanaesthesia.org
Study design should focus around meeting as many of the Bradford Hill criteria possible,
and the power and P-value chosen to achieve the highest possible study PPV and NPV …

Type 2 diabetes mellitus and COVID-19: a narrative review

C Rey-Reñones, S Martinez-Torres, FM Martín-Luján… - Biomedicines, 2022 - mdpi.com
Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and
prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values …

Safety and efficacy of inpatient diabetes management with non-insulin agents: an overview of international practices

RJ Galindo, K Dhatariya, F Gomez-Peralta… - Current diabetes …, 2022 - Springer
Abstract Purpose of Review The field of inpatient diabetes has advanced significantly over
the last 20 years, leading to the development of personalized treatment approaches …

Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care …

F Wu, MR Smith, AL Mueller, SA Klapman… - Canadian Journal of …, 2024 - Springer
Purpose We aimed to estimate the association of glucagon-like peptide 1 (GLP-1) receptor
agonist therapy with the incidence of endoscopically visible gastric contents after …

[HTML][HTML] Diabetic perioperative management

P Dogra, C Anastasopoulou, I Jialal - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Diabetic Perioperative Management - StatPearls - NCBI Bookshelf US flag An official website
of the United States government Here's how you know NIH NLM Logo Access keys NCBI …

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

AH Hulst, MJ Visscher, MB Godfried… - Diabetes, Obesity …, 2020 - Wiley Online Library
Aims Most cardiac surgery patients, with or without diabetes, develop perioperative
hyperglycaemia, for which intravenous insulin is the only therapeutic option. This is labour …